SLC2A1 and neoplasm: Liposomal systems demonstrate the most versatile improvements, with ginsenoside Rk1-loaded liposomes achieving 97.24% encapsulation efficiency while utilizing exposed Rk1 glycosides to reduce plasma protein adhesion and bind to GLUT1 proteins overexpressed on tumor cells [222].